Investor Relations
Mar 21, 2019
OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial MORE >>
Feb 27, 2019
OPKO Health Reports 2018 Fourth Quarter Business Highlights and Financial Results MORE >>
Feb 26, 2019
OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019 MORE >>
Feb 05, 2019
OPKO Health, Inc. Announces the Pricing of its Offering of Convertible Senior Notes MORE >>

SEC Filing Details

Document Details

Form
Filing Date
Jan 10, 2019
Document Date
Jan 9, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
OPKO Health, Inc.
Filer
FROST PHILLIP MD ET AL